Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 002603.SZ
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 3.58 B
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Market Capitalization is USD 3.58 B on January 14, 2025, a -32.80% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 5.33 B on January 15, 2024, which is 48.80% above the current Market Capitalization.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 3.40 B on July 04, 2024, which is -5.15% below the current Market Capitalization.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 4.13 B.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 002603.SZ
| CEO | Mr. Xiang Jun Wu |
| IPO Date | July 28, 2011 |
| Location | China |
| Headquarters | No. 238 Tianshan Street |
| Employees | 13,958 |
| Sector | Health Care |
| Industries | |
Description
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email